ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.2069T>C (p.Met690Thr) (rs397516128)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000628835 SCV000059410 likely pathogenic Hypertrophic cardiomyopathy 2018-11-30 criteria provided, single submitter clinical testing The p.Met690Thr variant in MYH7 has been reported in at least 2 individuals with HCM (Coppini 2014, Homburger 2016, Walsh 2017, LMM data). This variant has also been reported by another clinical laboratory in ClinVar (Variation ID 42876) an d was absent from large population studies. This variant was predicted to be pat hogenic using a computational tool clinically validated by our laboratory. This tool's pathogenic prediction is estimated to be correct 94% of the time (Jordan 2011). Additionally, the p.Met690Thr variant is located in the head domain of th e MYH7 protein, where studies have shown that missense variants in this region h ave been reported and statistically indicated to be more likely to cause disease (Walsh 2017). In summary, although additional studies are required to fully est ablish its clinical significance, this variant meets criteria to be classified a s likely pathogenic for autosomal dominant HCM. ACMG/AMP criteria applied: PM1, PM2, PP3, PS4_Supporting.
Invitae RCV000628835 SCV000749742 pathogenic Hypertrophic cardiomyopathy 2018-01-03 criteria provided, single submitter clinical testing This sequence change replaces methionine with threonine at codon 690 of the MYH7 protein (p.Met690Thr). The methionine residue is highly conserved and there is a moderate physicochemical difference between methionine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in several individuals affected with hypertrophic cardiomyopathy (PMID: 27532257, 27247418, 25524337). ClinVar contains an entry for this variant (Variation ID: 42876). A computational algorithm designed to assess the pathogenicity of variants in MYH7 with regard to hypertrophic cardiomyopathy predicted this sequence change to be deleterious. The algorithm has a sensitivity of 94% and a specificity of 89% (PMID: 21310275). For these reasons, this variant has been classified as Pathogenic.
CHEO Genetics Diagnostic Laboratory,Children's Hospital of Eastern Ontario RCV000770494 SCV000901939 uncertain significance Cardiomyopathy 2016-10-17 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.